Ertapenem-Induced Reduction in Valproate Levels: Case Report and Review of the Literature
Authors:
- 26 August 2010
- journal article
- review article
- Published by Canadian Society of Healthcare-Systems Pharmacy in The Canadian Journal of Hospital Pharmacy
- Vol. 63 (4) , 315-22
Abstract
Ertapenem-Induced Reduction in Valproate Levels: Case Report and Review of the LiteratureKeywords
This publication has 43 references indexed in Scilit:
- Clinical Pharmacokinetics and Pharmacodynamics of TigecyclineClinical Pharmacokinetics, 2009
- Pharmacokinetic Considerations regarding Tigecycline for Multidrug-Resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii UrosepsisJournal of Clinical Microbiology, 2009
- Effect of concomitant administration of meropenem and valproic acid in an elderly chinese patientThe American Journal of Geriatric Pharmacotherapy, 2009
- Meropenem y ácido valproico: una interacción a recordarAnales de Pediatría, 2009
- Acute Seizures in a Patient Receiving Divalproex Sodium After Starting Ertapenem TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Descripción de un caso de interacción farmacocinética entre ácido valproico e imipenemFarmacia Hospitalaria, 2006
- Seizure Worsening Caused by Decreased Serum Valproate During Meropenem TherapyJournal of Child Neurology, 2005
- Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayersInternational Journal of Pharmaceutics, 2002
- Panipenem, A Carbapenem Antibiotic, Enhances the Glucuronidation of Intravenously Administered Valproic Acid in RatsDrug Metabolism and Disposition, 1999
- Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacinJournal of Antimicrobial Chemotherapy, 1998